{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T17:36:12Z","timestamp":1772213772717,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd013733","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000}}],"reference-count":95,"publisher":"Wiley","issue":"2","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013733.pub2","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T12:26:06Z","timestamp":1675427166000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis"],"prefix":"10.1002","volume":"2023","author":[{"given":"Sherie","family":"Smith","sequence":"additional","affiliation":[{"name":"Lifespan and Population Health, School of Medicine; University of Nottingham; Nottingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Calthorpe","sequence":"additional","affiliation":[{"name":"Nottingham University Hospitals NHS Trust; Nottingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Herbert","sequence":"additional","affiliation":[{"name":"Lifespan and Population Health, School of Medicine; University of Nottingham; Nottingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan R","family":"Smyth","sequence":"additional","affiliation":[{"name":"Lifespan and Population Health; School of Medicine, University of Nottingham; Nottingham UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"10.1002\/14651858.CD013733.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S1569-1993(17)30358-2","article-title":"CFHealthHub: understanding psychosocial differences between high, medium and low adherers to nebuliser treatment: an exploratory analysis of data from CFHealthHub two centre pilot trial","volume":"16\u00a0Suppl 1","author":"Arden","year":"2017","journal-title":"Journal of Cystic Fibrosis"},{"issue":"1","key":"10.1002\/14651858.CD013733.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40814-020-00739-2","article-title":"Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub","volume":"7","author":"Arden","year":"2021","journal-title":"Pilot and Feasibility Studies"},{"issue":"10","key":"10.1002\/14651858.CD013733.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"e16782","DOI":"10.2196\/16782","article-title":"Mechanisms of action of a web-based intervention with health professional support to increase adherence to nebulizer treatments in adults with cystic fibrosis: qualitative interview study","volume":"22","author":"Drabble","year":"2020","journal-title":"Journal of Medical Internet Research"},{"issue":"1","key":"10.1002\/14651858.CD013733.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12890-019-0834-6","article-title":"Supporting medication adherence for adults with cystic fibrosis: a randomised feasibility study","volume":"19","author":"Hind","year":"2019","journal-title":"BMC Pulmonary Medicine"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/S1569-1993(17)30291-6","article-title":"CFHealthHub: complex intervention to support adherence to treatment in adults with cystic fibrosis: external pilot trial","volume":"16 Suppl 1","author":"Hind","year":"2017","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1002\/14651858.CD013733.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/thoraxjnl-2017-211453","article-title":"Role of habit in treatment adherence among adults with cystic fibrosis","volume":"74","author":"Hoo","year":"2019","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0007|cit7","unstructured":"A randomised controlled trial and parallel process evaluation to determine whether CFHealthHub, an intervention to help CF patients build better treatment habits, offers any benefit over usual care to adults with CF www.who.int\/trialsearch\/Trial2.aspx?TrialID=ISRCTN55504164\u00a0"},{"issue":"6","key":"10.1002\/14651858.CD013733.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40273-017-0500-x","article-title":"An early health economic analysis of the potential cost effectiveness of an adherence intervention to improve outcomes for patients with cystic fibrosis","volume":"35","author":"Tappenden","year":"2017","journal-title":"PharmacoEconomics"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0009|cit9","first-page":"S147","article-title":"Estimating adherence with nebulised therapies: a challenge for people with cystic fibrosis and healthcare professionals","volume":"19 Suppl 2","author":"Warnock","year":"2020","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0010|cit10","first-page":"265","article-title":"Effectiveness of a self-management intervention to support treatment adherence in adults with cystic fibrosis: a randomized controlled trial","volume":"55 Suppl 2","author":"Wildman","year":"2020","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0011|cit11","unstructured":"Wildman M Hutchings M Arden M O'Cathain A Drabble S Walters J Development and evaluation of an intervention to support adherence to treatment in adults with cystic fibrosis: a randomised controlled trial and parallel process evaluation. The University of Sheffield. Journal contribution figshare.shef.ac.uk\/articles\/journal_contribution\/Development_and_evaluation_of_an_intervention_to_support_Adherence_to_treatment_in_adults_with_Cystic_Fibrosis_A_randomised_controlled_trial_and_parallel_process_evaluation_protocol\/7338815 10.15131\/shef.data.7338815.v1"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0012|cit12","first-page":"92","article-title":"UK National CF healthhub programme: using real-time digital adherence data to support habit formation for self-care","volume":"54 Suppl 2","author":"Wildman","year":"2019","journal-title":"Pediatric Pulmonology"},{"issue":"11","key":"10.1002\/14651858.CD013733.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"[180 p.]","DOI":"10.3310\/pgfar09110","article-title":"An intervention to support adherence to inhaled medication in adults with cystic fibrosis: the ACtiF research programme including RCT","volume":"9","author":"Wildman","journal-title":"Programme Grants for Applied Research"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0014|cit14","unstructured":"Wildman MJ O'Cathain A Maguire C Arden MA Hutchings M Bradley J Self-management intervention to reduce pulmonary exacerbations by supporting treatment adherence in adults with cystic fibrosis: a randomised controlled trial Thorax 10.1136\/thoraxjnl-2021-217594"},{"issue":"5","key":"10.1002\/14651858.CD013733.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jcf.2011.04.006","article-title":"A randomised controlled trial of breathing modes for adaptive aerosol delivery in children with cystic fibrosis","volume":"10","author":"McCormack","year":"2011","journal-title":"Journal of Cystic Fibrosis"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD013733.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/S1569-1993(11)60230-0","article-title":"Open-label study: a comparison of breathing modes for adaptive aerosol delivery in children with cystic fibrosis","volume":"10","author":"McCormack","year":"2011","journal-title":"Journal of Cystic Fibrosis"},{"issue":"6","key":"10.1002\/14651858.CD013733.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1089\/jamp.2011.0934","article-title":"New nebulizer technology to monitor adherence and nebulizer performance in Cystic Fibrosis","volume":"25","author":"McCormack","year":"2012","journal-title":"Journal of Aerosol Medicine and Pulmonary Drug Delivery"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0018|cit18","first-page":"332","article-title":"Early intervention in pulmonary exacerbation","volume":"46 Suppl 34","author":"Aitken","year":"2011","journal-title":"Pediatric Pulmonology"},{"issue":"1","key":"10.1002\/14651858.CD013733.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jcf.2021.02.014","article-title":"Health care costs related to home spirometry in the eICE randomized trial","volume":"21","author":"Franz","year":"2022","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0020|cit20","first-page":"A5359","article-title":"Weekly adherence is high in an ongoing one year cystic fibrosis home monitoring trial in CF, the eICE study","volume":"189","author":"Goss","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0021|cit21","first-page":"342","article-title":"Assessment of the effectiveness of home monitoring trial in CF to identify and treat acute pulmonary exacerbation: the EICE study results","volume":"50 Suppl 41","author":"Goss","year":"2015","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0022|cit22","first-page":"353","article-title":"Effect of home spirometry on cost of pulmonary exacerbation management among CF patients","volume":"55 Suppl 2","author":"Kessler","year":"2020","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0023|cit23","first-page":"431","article-title":"The effect of home spirometry and symptom monitoring on treatment adherence in CF","volume":"50 Suppl 41","author":"Lechtzin","year":"2015","journal-title":"Pediatric Pulmonology"},{"issue":"9","key":"10.1002\/14651858.CD013733.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1164\/rccm.201610-2172OC","article-title":"Home monitoring of patients with cystic fibrosis to identify and treat acute pulmonary exacerbations. eICE study results","volume":"196","author":"Lechtzin","year":"2017","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013733.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cct.2013.09.004","article-title":"Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial","volume":"36","author":"Lechtzin","year":"2013","journal-title":"Contemporary Clinical Trials"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0026|cit26","unstructured":"Early intervention in cystic fibrosis exacerbation clinicaltrials.gov\/show\/NCT01104402"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0027|cit27","first-page":"289","article-title":"Home versus clinic spirometry to inform trial endpoints in CF: eICE experience","volume":"55 Suppl 2","author":"Paynter","year":"2020","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0028|cit28","first-page":"383","article-title":"Lung function recovery in cystic fibrosis following a pulmonary exacerbation treated with intravenous and oral antibiotics: analysis of the eICE\u00a0trial","volume":"52 Suppl 47","author":"Somayaji","year":"2017","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0029|cit29","first-page":"429","article-title":"Home monitoring of pulmonary exacerbation treatment in CF suggests ineffectiveness of oral antibiotics","volume":"54 Suppl 2","author":"VanDevanter","year":"2019","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0030|cit30","first-page":"345","article-title":"Design and planning of the early intervention in cystic fibrosis exacerbation randomized trial","volume":"46 Suppl 34","author":"West","year":"2011","journal-title":"Pediatric Pulmonology"},{"issue":"7","key":"10.1002\/14651858.CD013733.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"A760","DOI":"10.1016\/j.jval.2015.09.2480","article-title":"Adherence to inhaled antibiotics for the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis: a systematic literature review","volume":"18","author":"Agh","year":"2015","journal-title":"Value in Health"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/PPA.S53653","article-title":"Inhaled antibiotics for the treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients: challenges to treatment adherence and strategies to improve outcomes","volume":"10","author":"Bodnar","year":"2016","journal-title":"Patient Preference and Adherence"},{"issue":"4","key":"10.1002\/14651858.CD013733.pub2-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007639.pub2","article-title":"Nebuliser systems for drug delivery in cystic fibrosis","author":"Daniels","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0034|cit34","first-page":"329","article-title":"Long-term inhalation of hypertonic saline in patients with cystic fibrosis- a randomised controlled trial","volume":"38\u00a0Suppl 27","author":"Bye","year":"2004","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/S1569-1993(06)80426-1","article-title":"Three methods of monitoring adherence in a long-term trial in cystic fibrosis","volume":"5 Suppl","author":"Elkins","year":"2006","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0036|cit36","first-page":"268","article-title":"Three methods of monitoring adherence in the national hypertonic saline trial in cystic fibrosis","volume":"40\u00a0Suppl 28","author":"Elkins","year":"2005","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD013733.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa043900","article-title":"A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis","volume":"354","author":"Elkins","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013733.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpeds.2006.04.030","article-title":"Inhaled hypertonic saline produces small increases in lung function in patients with cystic fibrosis","volume":"149","author":"Ratjen","year":"2006","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0039|cit39","unstructured":"Randomised trial of a web-based intervention for adherence in cystic fibrosis www.who.int\/trialsearch\/Trial2.aspx?TrialID=ISRCTN37959826"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0040|cit40","unstructured":"An interactive program to improve care for children with CF clinicaltrials.gov\/show\/NCT00185549"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0041|cit41","unstructured":"CFfone: a cell phone support program for adolescents with cystic fibrosis clinicaltrials.gov\/ct2\/show\/NCT01183286"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0042|cit42","unstructured":"Muco smartphone exacerbation clinicaltrials.gov\/show\/NCT02122289"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0043|cit43","unstructured":"Interactive mobile health information to enhance patient care at a cystic fibrosis center clinicaltrials.gov\/show\/NCT03052231"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0044|cit44","unstructured":"Quittner AL Drotar D Ivers-Landis C Slocum N Buu A Measuring adherence to treatment in adolescents with cystic fibrosis: pros and cons of electronic monitoring 8th Florida Conference on Child Health Psychology; 2001 April 26; Gainesville (FL) 2001"},{"issue":"6","key":"10.1002\/14651858.CD013733.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jcf.2014.04.006","article-title":"Comparison of two tobramycin nebuliser solutions: pharmacokinetic, efficacy and safety profiles of T100 and TNS","volume":"13","author":"Sands","year":"2014","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0046|cit46","first-page":"S66","article-title":"A randomised comparison of VANTOBRA and TOBI in cystic fibrosis patients with chronic pseudomonas aeruginosa infection for pharmacokinetic and therapeutic equivalence","volume":"12 Suppl 1","author":"Sands","year":"2013","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0047|cit47","first-page":"P1188","article-title":"Use of an electronic monitoring system to generate objective information on patients' adherence to taking treatments of a novel inhaled tobramycin solution","volume":"42 Suppl 57","author":"Sands","year":"2013","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0048|cit48","first-page":"S66","article-title":"Use of an electronic monitoring system to generate objective information on patients' adherence to taking treatments of a novel tobramycin solution (VANTOBRA)","volume":"12 Suppl 1\u00a0","author":"Sands","year":"2013","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0049|cit49","unstructured":"Coaching and telemonitoring in patients with cystic fibrosis: connect CF www.trialsearch.who.int\/Trial2.aspx?TrialID=DRKS00024642"},{"issue":"1","key":"10.1002\/14651858.CD013733.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12890-021-01500-y","article-title":"A multi-centre, randomized, controlled trial on coaching and telemonitoring in patients with cystic fibrosis: conneCT CF","volume":"21","author":"Thee","year":"2021","journal-title":"BMC Pulmonary Medicine"},{"issue":"3","key":"10.1002\/14651858.CD013733.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1081-1206(10)63001-3","article-title":"Nonadherence in asthmatic patients: is there a solution to the problem?","volume":"79","author":"Bender","year":"1997","journal-title":"Annals of Allergy, Asthma & Immunology"},{"issue":"5","key":"10.1002\/14651858.CD013733.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"pii: 1801147","DOI":"10.1183\/13993003.01147-2018","article-title":"Digital technologies and adherence in respiratory diseases: the road ahead","volume":"52","author":"Blakey","year":"2018","journal-title":"European Respiratory Journal"},{"issue":"1","key":"10.1002\/14651858.CD013733.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/thoraxjnl-2019-213233","article-title":"Using digital technology for home monitoring, adherence and self-management in cystic fibrosis: a state-of-the-art review","volume":"75","author":"Calthorpe","year":"2019","journal-title":"Thorax"},{"issue":"1","key":"10.1002\/14651858.CD013733.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"e000601","DOI":"10.1136\/bmjresp-2020-000601","article-title":"What effective ways of motivation, support and technologies help people with cystic fibrosis improve and sustain adherence to treatment?","volume":"7","author":"Calthorpe","year":"2020","journal-title":"BMJ Open Respiratory Research"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0055|cit55","unstructured":"Cystic Fibrosis Foundation About cystic fibrosis www.cff.org\/"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0056|cit56","unstructured":"Cystic fibrosis insight survey - report on the 2017 and 2018 surveys www.cysticfibrosis.org"},{"key":"#cr-split#-10.1002\/14651858.CD013733.pub2-BIB0057|cit57.1","unstructured":"UK Cystic fibrosis registry annual data report 2020"},{"key":"#cr-split#-10.1002\/14651858.CD013733.pub2-BIB0057|cit57.2","unstructured":"December 2021 Available at www.cysticfibrosis.org.uk\/sites\/default\/files\/2021-12\/CF_Annual%20Report%202020_V8.pdf"},{"issue":"7","key":"10.1002\/14651858.CD013733.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1111\/bcp.14193","article-title":"The medication adherence report scale: a measurement tool for eliciting patients' reports of nonadherence","volume":"86","author":"Chan","year":"2020","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0059|cit59","unstructured":"Covidence Veritas Health Innovation"},{"issue":"2","key":"10.1002\/14651858.CD013733.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1378\/chest.09-3074","article-title":"Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers","volume":"140","author":"Daniels","year":"2011","journal-title":"Chest"},{"issue":"3","key":"10.1002\/14651858.CD013733.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcf.2019.10.025","article-title":"Characterising burden of treatment in cystic fibrosis to identify priority areas for clinical trials","volume":"19","author":"Davies","year":"2020","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0062|cit62","unstructured":"Deeks JJ Higgins JP Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD013733.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2011.03.005","article-title":"Longitudinal association between medication adherence and lung health in people with cystic fibrosis","volume":"10","author":"Eakin","year":"2011","journal-title":"Journal of Cystic Fibrosis"},{"issue":"6","key":"10.1002\/14651858.CD013733.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/MCP.0b013e3283659f45","article-title":"The impact of medication adherence on lung health outcomes in cystic fibrosis","volume":"19","author":"Eakin","year":"2013","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013733.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD013733.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/s41431-018-0234-z","article-title":"Estimating the age of p.(Phe508del) with family studies of geographically distinct European populations and the early spread of cystic fibrosis","volume":"26","author":"Farrell","year":"2018","journal-title":"European Journal of Human Genetics"},{"issue":"10","key":"10.1002\/14651858.CD013733.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM199409083311003","article-title":"Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis","volume":"331","author":"Fuchs","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1002\/14651858.CD013733.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/thorax.55.11.946","article-title":"Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis","volume":"55","author":"Gee","year":"2000","journal-title":"Thorax"},{"issue":"4","key":"10.1002\/14651858.CD013733.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1513\/pats.200703-039BR","article-title":"Patient-reported outcomes in cystic fibrosis","volume":"4","author":"Goss","year":"2007","journal-title":"American Thoracic Society"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0070|cit70","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Risk of bias in a randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane 2022 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0071|cit71","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0072|cit72","unstructured":"Higgins JP Eldridge S Li T Chapter 23 Including variants on randomized trials. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook"},{"issue":"9","key":"10.1002\/14651858.CD013733.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1164\/rccm.201610-2172OC","article-title":"Home monitoring of patients with cystic fibrosis to identify and treat acute pulmonary exacerbations. eICE study results","volume":"196","author":"Lechtzin","year":"2017","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013733.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcf.2009.04.006","article-title":"Open adherence monitoring using routine data download from an adaptive aerosol delivery nebuliser in children with cystic fibrosis","volume":"8","author":"McNamara","year":"2009","journal-title":"Journal of Cystic Fibrosis"},{"issue":"1","key":"10.1002\/14651858.CD013733.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/02739610701766925","article-title":"The influence of parental supervision on medical adherence in adolescents with cystic fibrosis: developmental shifts from pre to late adolescence","volume":"37","author":"Modi","year":"2008","journal-title":"Children's Health Care"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0076|cit76","unstructured":"National Health Service NHS long-term plan. Chapter 5: Digitally enabled care will go mainstream across the NHS Available at www.longtermplan.nhs.uk\/online-version 2019"},{"issue":"12","key":"10.1002\/14651858.CD013733.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/ppul.23317","article-title":"Adherence to airway clearance therapy in pediatric cystic fibrosis: socioeconomic factors and respiratory outcomes","volume":"50","author":"Oates","year":"2015","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0078|cit78","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3\u00a0(updated February\u00a02022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD013733.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jcf.2007.07.008","article-title":"Gender differences in treatment adherence among youth with cystic fibrosis: development of a new questionnaire","volume":"7","author":"Patterson","year":"2008","journal-title":"Journal of Cystic Fibrosis"},{"issue":"9","key":"10.1002\/14651858.CD013733.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/jpepsy\/jsm064","article-title":"Evidence-based assessment of adherence to medical treatments in pediatric psychology","volume":"33","author":"Quittner","year":"2008","journal-title":"Journal of Pediatric Psychology"},{"issue":"6","key":"10.1002\/14651858.CD013733.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1378\/chest.08-1190","article-title":"Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection","volume":"135","author":"Quittner","year":"2009","journal-title":"Chest"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0082|cit82","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2019"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0083|cit83","unstructured":"RoB2 Excel tool Available at riskofbias.info"},{"issue":"4","key":"10.1002\/14651858.CD013733.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/thoraxjnl-2017-210473","article-title":"The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers","volume":"73","author":"Rowbotham","year":"2018","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0085|cit85","first-page":"373","article-title":"Understanding the treatment burden in cystic fibrosis: a step towards a trial of stopping treatment?","volume":"53 Suppl 2","author":"Rowbotham","year":"2018","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0086|cit86","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). \u00a0Cochrane, 2022 \u00a0Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0087|cit87","unstructured":"Sch\u00fcnemann HJ Vist GE Higgins JP Santesso N Deeks JJ Glasziou P Chapter 15: Interpreting results and drawing conclusions. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 \u00a0Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0088|cit88","unstructured":"Smith S Calthorpe R Herbert S Cochrane Review: Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis - risk of bias decisions doi.org\/10.6084\/m9.figshare.19077011.v1\u00a0 2022 10.6084\/m9.figshare.19077011.v1"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0089|cit89","unstructured":"SPSS Statistical Package for the Social Sciences IBM Corporation 2017"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"Suppl 57","key":"10.1002\/14651858.CD013733.pub2-BIB0091|cit91","first-page":"P2113","article-title":"Self-perceived verses electronic monitoring of adherence to nebulised treatment in children with cystic fibrosis - does the use of telehealth system improve nebulisation adherence?","volume":"42","author":"Thorton","year":"2013","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD013733.pub2-BIB0092|cit92","unstructured":"World Health Organization Global Strategy on Digital Health 2020 - 2024 www.raps.org\/news-and-articles\/news-articles\/2019\/4\/who-drafts-global-strategy-on-digital-health"},{"issue":"6","key":"10.1002\/14651858.CD013733.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jaci.2004.09.028","article-title":"Relationship between adherence to inhaled corticosteroids and poor outcomes among adults with asthma","volume":"114","author":"Williams","year":"2004","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"9","key":"10.1002\/14651858.CD013733.pub2-BIB0094|cit94","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013733","article-title":"Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis","author":"Smith","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd013733.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T02:18:14Z","timestamp":1693189094000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013733.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":95,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013733.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]}}}